[1]
U. Bakay, T. I. Duran, O. S. Karstarli Bakay, and R. Ekmekcioglu, “Hepatic Safety of IL-17 Inhibitors in Psoriasis and Psoriatic Arthritis: A 12-Month Retrospective Cohort Evaluation Using the FIB-4 Index”, Dermatol Pract Concept, vol. 16, no. 1, p. 6746, Jan. 2026, doi: 10.5826/dpc.1601a6746.